Clearstead Advisors’s Verona Pharma VRNA Stock Holding History

Clearstead Advisors’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-500	Closed	-$53.4K	–	3274
2025 Q3	$53.4K	Sell	500 -1,156	-70%	-$121K	﹤0.01%	1258
2025 Q2	$157K	Sell	1,656 -10,344	-86%	-$766K	﹤0.01%	946
2025 Q1	$762K	Hold	12,000	–	–	0.01%	471
2024 Q4	$557K	Sell	12,000 -1,000	-8%	-$37.5K	0.01%	550
2024 Q3	$374K	Sell	13,000 -10,000	-43%	-$246K	0.01%	647
2024 Q2	$333K	Buy	+23,000	New	+$336K	0.01%	644

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Clearstead Advisors's VRNA Position: Q4 2025 in Review

Clearstead Advisors sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 500 shares — an estimated $53.4K sold.

Clearstead Advisors first reported a position in VRNA in Q2 2024 and held it in 6 quarters. The position peaked at $762K in Q1 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Clearstead Advisors reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Clearstead Advisors sold 500 Verona Pharma shares in Q4 2025, an estimated $53.4K.
Clearstead Advisors first reported a position in Verona Pharma in Q2 2024 and held it in 6 quarters.
Clearstead Advisors's Verona Pharma position peaked at $762K in Q1 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Clearstead Advisors's 13F filing for Q4 2025, filed 9 Feb 2026.